Pharmacokinetics of N-acetylcysteine following repeated intravenous infusion in haemodialysed patients

European Journal of Clinical Pharmacology

Volumn 60, Issue 12, 2005, Pages 859-864

  Soldini, Davide ^a   Zwahlen, Hugo ^a   Gabutti, Luca ^b   Marzo, Antonio ^c   Marone, Claudio ^a  

^a REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^b Ospedale Regionale di Locarno   (Switzerland)

^c IPAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; LOW MOLECULAR WEIGHT HEPARIN; MUCOLYTIC AGENT; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; FEMALE; HEMODIALYSIS; HUMAN; MALE; OPEN STUDY; PLASMA CLEARANCE; PRIORITY JOURNAL; SIDE EFFECT; STEADY STATE;

ACETYLCYSTEINE; AGED; ANTIOXIDANTS; AREA UNDER CURVE; BLOOD UREA NITROGEN; CYSTEINE; DRUG ADMINISTRATION SCHEDULE; EXPECTORANTS; FEMALE; GLUTATHIONE; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PILOT PROJECTS; RENAL DIALYSIS;

EID: 15244353612     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-004-0850-0     Document Type: Article

References (21)

1. Lindner A, Charra B, Sherrand DJ, Scribner BH (1974) Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697-701
2. Hakim R (1993) Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 44:484-494
3. Alvarez V, Pulido R, Companero MR et al (1991) Differentially regulated cell surface expression of leukocyte adhesion receptors on neutrophils. Kidney Int 40:899-905
4. Amaout M, Hakim R, Todd R et al (1985) Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med 312:457-462
5. Kuwahara T, Markert M, Wauters JP (1988) Neutrophil oxygen radical production by dialysis membranes. Nephrol Dial Transplant 3:661-665
6. Nguyen AT, Lethias C, Zingraff J et al (1985) Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within micro amounts of whole blood. Kidney Int 28:158-167
7. Kolb G, Noiting C, Eckle I et al (1985) The role of membrane contact in hemodialysis-induced granulocyte activation. Nephron 57:64-68
8. Hirnmelfarb J, Ault KA, Holbrook D et al (1993) Intradialytic granulocyte reactive oxygen species production: a prospective, crossover trial. J Am Soc Nephrol 4:178-186
9. Becker BN, Himmelfarb J, Henrich WL et al (1997) Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol 8:475-486
10. Boaz M, Matas Z, Biro A et al (1999) Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. Kidney Int 56:1078-1083
11. Suliman ME et al (2000) Hyperhomocysteinemia. Nutritional status and cardiovascular disease in hemodialysis patients. Kidney Int 57:1727-1735
12. Martindale (1999) The complete drug reference, 32nd edn. K. Parfitted, pp 1052-1054
13. Santangelo F, Witko-Sarsat V, Drüeke T, Descamps-Latscha B (2004) Restoring glutathione as a therapeutic strategy in chronic kidney disease. Nephrol Dial Transplant 19:1951-1955
14. Tepel M, Van der Giet M, Statz M, Jankowski J, Zidek W (2003) The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure. Circulation 107:992-995
15. Holdiness MR (1991) Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet 20:123-134
16. Jones AL, Jarvie DR, Simpson D, Hayes PC, Prescott LF (1997) Pharmacokinetics of N-acetylcysteine are altered in patients with chronic liver disease. Aliment Pharmacol Ther 11(4):787-791
17. Tepel M, Van der Giet M, Schwarzfeld C, Laufer U, Liermann D (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180-184
18. Durham JD, Caputo C, Dokko J et al (2002) A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 62:2202-2207
19. Allaqaband S, Tumuluri R, Malik AM et al (2002) Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 57:279-283
20. Pannu N, Manns B, Lee H, Tonelli M (2004) Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 65:1366-1374
21. Drüeke TB, Descamps-Latscha B, Locatelli F (2003) Stopping a medical research project for financial reasons. Nephrol Dial Transplant 18:1982-1983